Occurrence and removal of pharmaceuticals at an Australian sewage treatment plant

Water

Volumn 32, Issue 4, 2005, Pages 80-85

  Khan, S J ^a   Ongerth, J E ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Regulatory Planning and Analysis   (United States)

Author keywords

PhACs; Sewage; Treatment

Indexed keywords

CONCENTRATION (PROCESS); DRUG PRODUCTS; EXTRACTION; GAS CHROMATOGRAPHY; MASS SPECTROMETRY; SEWAGE SLUDGE; SEWAGE TREATMENT; SEWAGE TREATMENT PLANTS;

ACTIVATED SLUDGE; BIOREMEDIATION; DRUG; SEWAGE TREATMENT;

EID: 33747061840     PISSN: 03100367     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (12)

1. Carballa M, Omil F, Lema JM, Llompart M, Garcia-Jares C, Rodriguez I, Gomez M, Ternes T. (2004) Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res. 38 (12):2918-2926.
2. Cleuvers M. (2004) Mixture toxicity of the antiinflammatory drugs diclofenac, ibuprofen, naproxen, and acetylsalicylic acid. Ecotox. Environ. Safe. 59 (3):309-315.
3. Debska J, Kot-Wasik A, Namiesnik J. (2004) Fate and analysis of pharmaceutical residues in the aquatic environment. Crit. Rev. Anal. Chem. 34 (1):51-67.
4. Jones AH, Voulvoulis N, Lester JN. (2004) Potential ecological and human health risks associated with the presence of pharmaceutically active compounds in the aquatic environment. Crit. Rev. Toxicol 34 (4):335-350.
5. Khan SJ, Ongerth JE. (2002) Estimation of pharmaceutical residues in primary and secondary sewage sludge based on quantities of use and fugacity modelling. Water Sci. Technol. 46 (3):105-113.
6. Khan SJ, Ongerth JE. (2004) Modelling of prescription pharmaceutical residues in Australian sewage based on quantities of use and fugacity calculations. Chemosphere 54 (3):355-367.
7. Richards SM, Wilson CJ, Johnson DJ, Castle DM, Lam M, Mabury SA, Sibley PK, Solomon KR. (2004) Effects of pharmaceutical mixtures in aquatic microcosms. Environ. Toxicol. Chem. 23 (4):1035-1042.
8. Sanderson H, Johnson DJ, Reitsma T, Brain RA, Wilson CJ, Solomon KR. (2004) Ranking and prioritization of environmental risks of pharmaceutical in surface waters. Regul. Toxicol Pharm. 39:158-183.
9. Ternes TA, Hirsch R, Mueller J, Haberer K. (1998) Methods for the determination of neutral drugs as well as betablockers and b2-sympathomimetics in aqueous matrices using GC/MS and LC/MS/MS. Fresenius J. Anal. Chem. 362:329-340.
10. Thomas PM, Foster GD. (2005) Tracking acidic pharmaceutical, caffeine, and triclosan through the wastewater treatment process. Environmental Toxicology and Chemistry 24 (1):25-30.
11. Weigel S, Berger U, Jensen E, Kallenborn R, Thoresen H, Huhnerfuss H. (2004) Determination of selected pharmaceuticals and caffeine in sewage and seawater from Tromso/Norway with emphasis on ibuprofen and its metabolites. Chemosphere 56 (6):583-592.
12. Ying GG, Kookana RS. (2002) Endocrine disruption: An Australian perspective. Water 29 (9):42-45.